Sufficient Immunosuppression with Thymoglobulin Is Essential for a Successful Haplo-Myeloid Bridge in Haploidentical-Cord Blood Transplantation
Caroline A. Lindemans(University Medical Center Utrecht), Jaap Jan Boelens(Wilhelmina Children's Hospital), A. M. J. Wensing(University Medical Center Utrecht), Rick Admiraal(NHS Blood and Transplant), Els C. Jol‐van der Zijde(Leiden University Medical Center), Marc Bierings(University Medical Center Utrecht), A. Birgitta Versluijs(NHS Blood and Transplant), L.C.J. te Boome(University Medical Center Utrecht), Jürgen Kuball(Utrecht University)
Cited by 21
Related Papers
Gut microbiome–derived metabolites modulate intestinal epithelial cell damage and mitigate graft-versus-host disease
|Nature Immunology|2016|727
Early cytomegalovirus reactivation remains associated with increased transplant-related mortality in the current era: a CIBMTR analysis
|Blood|2016|554
Hematopoietic stem cell transplantation in Europe 2014: more than 40 000 transplants annually
|Bone Marrow Transplantation|2016|396